A private online GP service, DutyDoctor, founded by Dr Koyes Ahmed, took to LinkedIn to announce that the company has reached a financial crossroads and is now looking for “urgent investment or partnership” to help secure its future.
Founded in February 2025, DutyDoctor provides private online consultations, prescriptions, medical letters, blood and urine tests, scans, ECGs and specialist referrals. According to Koyes, the company has seen a number of key milestones over the past six months, growing from a team of one to a team of four and onboarding 10 partnership organisations; however this has been personally funded by Koyes himself.
The online GP service aims to offer an option providing same day or next day online consultations, it notes, as well providing services for business to support their employees.
“Unfortunately I’ve now reached the limit of what I can sustain alone,” he shared .”Without urgent investment or partnership, I’m saddened to say that DutyDoctor won’t be able to continue beyond August – and this could be our last month.” Due to a lack of investment, Koyes is now looking for external funding, asking for a collaboration or partnership that will allow the company to “grow and scale sustainably”.
2025 funding landscape for healthcare companies
Quiddity Health, the UK-based health tech consultancy service, recently announced it will be ending its services after five years of operation, citing delayed revenue and slow new business across the VC and health tech market as the main reason behind this decision. The announcement was also made on LinkedIn by founder and CEO of Quiddity Health, Gavin Matthews, who shared that “lost contracts and slower than expected new business” have all led to the closure of the company.
Digital healthcare platform Numan managed to raise £45 million in Series B funding to support the company’s continued growth and expansion into wider international markets. Big Pi Ventures led the round of funding, offering £22 million in investment to support the development of tech solutions, with £20 million in growth capital came from HSBC Innovation Banking, allowing Numan to expand overseas.
Earlier in the year, health tech company Skin Analytics raised £15 million in Series B funding to increase their product offering and expand overseas. Led by AI-focused investor, Intrepid Growth Partners, the funding is being used to “launch products that cover all dermatology concerns”. It will also help Skin Analytics to increase their reach to Europe, Australia and the US.
